Works matching IS 03065251 AND DT 2013 AND VI 76 AND IP 2
Results: 15
Clinical pharmacological properties of mipomersen ( Kynamro), a second generation antisense inhibitor of apolipoprotein B.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 76, n. 2, p. 269, doi. 10.1111/j.1365-2125.2012.04469.x
- By:
- Publication type:
- Article
A next step in adeno-associated virus-mediated gene therapy for neurological diseases: regulation and targeting.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 76, n. 2, p. 217, doi. 10.1111/bcp.12065
- By:
- Publication type:
- Article
Stratified approaches to the treatment of asthma.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 76, n. 2, p. 277, doi. 10.1111/bcp.12036
- By:
- Publication type:
- Article
Giving monoclonal antibodies to healthy volunteers in phase 1 trials: is it safe?
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 76, n. 2, p. 164, doi. 10.1111/bcp.12096
- By:
- Publication type:
- Article
Biological therapies: a long way on from Jenner.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 76, n. 2, p. 161, doi. 10.1111/bcp.12202
- By:
- Publication type:
- Article
A novel assay to measure B cell responses to keyhole limpet haemocyanin vaccination in healthy volunteers and subjects with systemic lupus erythematosus.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 76, n. 2, p. 188, doi. 10.1111/bcp.12172
- By:
- Publication type:
- Article
Severity of the TGN1412 trial disaster cytokine storm correlated with IL-2 release.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 76, n. 2, p. 299, doi. 10.1111/bcp.12165
- By:
- Publication type:
- Article
Drug-conjugated antibodies for the treatment of cancer.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 76, n. 2, p. 248, doi. 10.1111/bcp.12044
- By:
- Publication type:
- Article
How biologics targeting the IL-1 system are being considered for the treatment of type 2 diabetes.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 76, n. 2, p. 263, doi. 10.1111/j.1365-2125.2012.04297.x
- By:
- Publication type:
- Article
Gene doping: gene delivery for olympic victory.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 76, n. 2, p. 292, doi. 10.1111/bcp.12010
- By:
- Publication type:
- Article
Novel antibodies targeting immune regulatory checkpoints for cancer therapy.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 76, n. 2, p. 233, doi. 10.1111/bcp.12164
- By:
- Publication type:
- Article
Towards a universal influenza vaccine: volunteer virus challenge studies in quarantine to speed the development and subsequent licensing.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 76, n. 2, p. 210, doi. 10.1111/bcp.12146
- By:
- Publication type:
- Article
British Journal of Clinical Pharmacology.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 76, n. 2, p. i, doi. 10.1111/j.1365-2125.2012.04435.x
- Publication type:
- Article
A pharmacologic perspective on newly emerging T-cell manipulation technologies.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 76, n. 2, p. 173, doi. 10.1111/j.1365-2125.2012.04475.x
- By:
- Publication type:
- Article
A regulatory perspective of clinical trial applications for biological products with particular emphasis on Advanced Therapy Medicinal Products ( ATMPs).
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 76, n. 2, p. 203, doi. 10.1111/bcp.12057
- By:
- Publication type:
- Article